Shots: The companies collaborate with the Yangtze to commercialize eight biosimilars in China. The initial pipeline contains biosimilar candidates for the treatment of autoimmunity, ophthalmology, and oncology Alvotech and Alvotech […]readmore
Tags : Exclusive Commercialization Agreement
Shots: Lotus to get an exclusive commercialization right of biosimilar Darbepoetin alfa in Taiwan and Southeast Asian markets The collaboration allows the Lotus to re-emphasize its focus on nephrology as […]readmore